TETRAPHASE PHARMACEUTICALS INC: accounts_receivable

Value{"amount": 2912000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"}
Period (as of 2013-06-30)
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-13-331037 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:17.864451+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/accounts-receivable/2013-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/3f2d441d-3a82-48bd-a340-d3dc96fd022d

History

From the Record